-
Healthcare Resource Utilization of Tafamidis Patients in the United States
Mar 10, 2025, 14:00 PM -
Inclusion of Health-Related Quality of Life (HRQoL) and Other Patient-Reported Outcomes (PROs) in the United States Food and Drug Administration (FDA) Labels
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Tumor-Treating Fields in Combination With Temozolomide for Glioblastoma Patients: An Italian Healthcare System Perspective
Mar 10, 2025, 14:00 PM -
Evaluating the Association Between Medicare Star Ratings Part D Medication Adherence Measures and the Part C Plan All-Cause Readmission Outcome Measure
Mar 10, 2025, 14:00 PM -
Economic Impact of Trastuzumab and Its Biosimilars for the Treatment of HER2-Positive Breast Cancer Patients: A Real-World Study in the US
Mar 10, 2025, 14:00 PM -
Increasing Recognition Towards Inclusion of Patient Preferences in Healthcare Intervention Development and Access- Current Landscape and Way Forward
Mar 10, 2025, 14:00 PM -
Sociodemographic Determinants and Inequities in Prenatal Healthcare in the Canadian Province of Manitoba: A Population-Based Cohort Study 2010-2022
Mar 10, 2025, 14:00 PM -
A Reanalysis of Canada's Drug Agency (CDA) Reports: Do Conclusions from Cost-Effectiveness Analyses Using Quality-Adjusted Life-Years (QALYs) Hold When Evaluating with Equal Value of Life-Years Gained (evLYG)?
Mar 10, 2025, 14:00 PM -
Evolving Trends in Racial and Ethnic Disparities in Syphilis Prevalence Among People Who are Pregnant in The United States from 2016 To 2023
Mar 10, 2025, 14:00 PM -
Patient-Centric Factors in AI Chatbot Adoption for Healthcare
Mar 10, 2025, 14:00 PM -
Experiences of Hungarian Mothers About Breastfeeding Support From Health Visitors
Mar 10, 2025, 14:00 PM -
Examining Factors Contributing to Age of Late-Onset Autoimmune Disease in U.S. Adults Using Hierarchical Clustering Mechanisms
Mar 10, 2025, 14:00 PM -
Assessing the Proportion of Days Covered within 180 Days after First Medication Fills Among Bipolar Disorder Patients Using Real-World Data
Mar 10, 2025, 14:00 PM -
The Impact of CDA-AMC Sequential Analysis on Decision-Making in Oncology
Mar 10, 2025, 14:00 PM -
Validation of a Flexible Partitioned Survival and 3-State Markov Model for Cost-Effectiveness Analyses in Oncology
Mar 10, 2025, 14:00 PM -
Gabapentinoid Use, Potential Misuse, and Associated Risk Factors among U.S. Adult Cancer Survivors: A Retrospective Cohort Study
Mar 10, 2025, 14:00 PM -
Structured Evaluation of Oncology Real-World Data Quality for Practical Applications
Mar 10, 2025, 14:00 PM -
Using Real-World Data and Machine Learning to Identify Patients at Highest Risk for Hospitalization Following Respiratory Syncytial Virus Infection
Mar 10, 2025, 14:00 PM -
Surgical Stripping and Ligation Compared to Cyanoacrylate Vein Closure in the Mexican Public Healthcare Setting: Direct Costs and Incapacity Pay
Mar 10, 2025, 14:00 PM -
Automated Extraction of Kaplan-Meier Survival Curves Using Generative Artificial Intelligence and Computer Vision
Mar 10, 2025, 14:00 PM
